ArticleAmerican journal of clinical oncology2019

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.

Wen Wee Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.